Sean T. Agbor-Enoh

Summary

Sean T. Agbor-Enoh. Role: ORCID lists "Snior Lasker Clinical Research Investigator" (Pulmonary Branch-Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute); "Professor (Adjunct)" (Lung Transplantation Program, Medicine, Johns Hopkins Hospital). Basis of the role: ORCID employment entries without an end date (self-asserted by the record holder, may be out of date). Field indicated by the unit name: respiratory medicine (source: the same ORCID entries). Affiliation: National Heart, Lung, and Blood Institute, Bethesda (US); Johns Hopkins Hospital, Baltimore (US). Basis: ORCID record, employment entries without an end date (self-asserted, may be out of date). Counts in the OpenAlex corpus (retrieved 2026-10-10): 32 papers and 456 citations over ten years; 4 first-author and 22 last-author papers. Ranks: main 59, excluding consensus papers 50, first or last author 10. The method is stated once on the People list page. Linked papers are the most-cited corpus papers of this author.

Citation ranks (10 years)

Citations: 456 in total, 440 excluding consensus and guideline papers (2 of this author's papers excluded), 419 on first or last author papers (4 first, 22 last).

Role and field

Role

"Snior Lasker Clinical Research Investigator" (Pulmonary Branch-Laboratory of Applied Precision Omics, National Heart, Lung, and Blood Institute); "Professor (Adjunct)" (Lung Transplantation Program, Medicine, Johns Hopkins Hospital)

Role status

verified from ORCID (self-asserted entries; may be out of date)

Role basis

ORCID employment entries without an end date (self-asserted by the record holder, may be out of date)

Field

respiratory medicine

Field basis

the same ORCID entries

Only what a cited source supports is stated. Entries marked self-asserted come from the person's own ORCID record. The field is taken from the name of the unit, not inferred from the person's name.

Details

affiliation

National Heart, Lung, and Blood Institute, Bethesda (US); Johns Hopkins Hospital, Baltimore (US)

papers 10y

32

fractional papers 10y

3.13

citations 10y

456

fractional citations 10y

36.7

ranking retrieved

2026-10-10

orcid

0000-0002-9380-9161

openalex author id

A5071872556

merged open alex profiles

2

affiliation basis

ORCID record, employment entries without an end date (self-asserted, may be out of date)

papers excluding consensus 10y

30

citations excluding consensus 10y

440

consensus papers excluded 10y

2

first author papers 10y

4

last author papers 10y

22

lead author citations 10y

419

lead author papers 10y

26

Sources and links

• ORCID record (role and affiliation entries are self-asserted) (primary)
• OpenAlex author profile (ranking source)
• Most-cited CLAD paper in corpus: Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD) (The Journal of Heart and Lung Transplantation, 2021); 55 citations; DOI 10.1016/j.healun.2021.02.008
• Most-cited CLAD paper in corpus: Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death (American Journal of Transplantation, 2023); 27 citations; DOI 10.1016/j.ajt.2022.12.019
• Most-cited CLAD paper in corpus: The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease (Blood Advances, 2022); 16 citations; DOI 10.1182/bloodadvances.2021006885
• Most-cited CLAD paper in corpus: Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease (The Journal of Heart and Lung Transplantation, 2024); 16 citations; DOI 10.1016/j.healun.2024.04.064
• Most-cited CLAD paper in corpus: Donor–derived cell-free DNA associated with increased risk of chronic lung allograft dysfunction and mortality: Are absolute levels better than percentage? (The Journal of Heart and Lung Transplantation, 2026); 9 citations; DOI 10.1016/j.healun.2026.01.022
• ORCID employment entries (source of the role)

Known gaps in this record

• centre membership relation (not asserted)
• funding and conflicts of interest
• only the top-30 entries were checked by hand for ID merges and splits